Global Humanized Mice Model Market Report 2020: Historical Years 2015-2018 / Base Year of 2019 / Estimated Year, 2020 / Forecasts 2021-2025 - ResearchAndMarkets.com

·4 min read

The "Global Humanized Mice Model Market, by Service (Breeding, Model-In licensing, Genetic testing and Others), by Type, by Immune Checkpoints, by Application, by End-user, by Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

Major players operating in the Global Humanized Mice Model Market include Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd, Horizon Discovery Group, Ingenious Targeting Laboratory, Biocytogen, Taconic Biosciences and others.

The Objectives of the Study:

  • To analyze and estimate the market size of the Global Humanized Mice Model Market from 2015 to 2018.

  • To estimate and forecast the market size of the Global Humanized Mice Model Market from 2019 to 2025.

  • To classify and forecast the Global Humanized Mice Model Market based on service, type, immune checkpoints, service, application, end-use, company and regional distribution.

  • To identify dominant region or segment in the Global Humanized Mice Model Market.

  • To identify drivers and challenges for the Global Humanized Mice Model Market.

  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Humanized Mice Model Market.

  • To conduct pricing analysis for the Global Humanized Mice Model Market.

  • To identify and analyze the profile of leading players operating in the Global Humanized Mice Model Market.

  • To identify key sustainable strategies adopted by market players in the Global Humanized Mice Model Market.

Key Target Audience:

  • Humanized mice model research labs/institutes, end-users and other stakeholders

  • Government bodies such as regulating authorities and policy makers

  • Organizations, forums and alliances related to humanized mice model

  • Market research and consulting firms

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Humanized Mice Model Market

4. Executive Summary

5. Voice of Customer

6. Global Humanized Mice Model Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Service (Breeding, Model In-Licensing, Genetic Testing, Other Services)

6.2.2. By Type (Cell-line transplantation model, Patient based xenografts, Genetically Engineered Mice, Others)

6.2.3. By Immune Checkpoints (PD-1, CTLA-4, CD-39, Others)

6.2.4. By Application (Immuno-Oncology Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Other Type Studies)

6.2.5. By End-user (Companies {Pharmaceutical, BioService, Academic and Research Institutes, Contract Research Organizations)

6.2.6. By Company

6.2.7. By Region

6.3. Market Attractiveness Index

7. Asia-Pacific Humanized Mice Model Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Service

7.2.2. By Type

7.2.3. By Application

7.2.4. By Immune Check Points

7.2.5. By End User

7.2.6. By Country

7.3. Asia-Pacific: Country Analysis

8. Europe Humanized Mice Model Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Service

8.2.2. By Type

8.2.3. By Application

8.2.4. By Immune Check Points

8.2.5. By End User

8.2.6. By Country

8.3. Europe: Country Analysis

9. North America Humanized Mice Model Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Service

9.2.2. By Type

9.2.3. By Application

9.2.4. By Immune Check Points

9.2.5. By End User

9.2.6. By Country

9.3. North America: Country Analysis

10. Rest of World Mice Humanized Model Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Service

10.2.2. By Type

10.2.3. By Application

10.2.4. By Immune Check Points

10.2.5. By End User

10.2.6. By Country

10.3. Rest of World: Country Analysis

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

13.1. Charles River Laboratories, Inc.

13.2. The Jackson Laboratory

13.3. GemPharmatech Co.,Ltd

13.4. Taconic Biosciences, Inc.

13.5. Envigo (Harlan Laboratories, Inc.)

13.6. Laboratory Corporation of America Holdings

13.7. Janvier Labs

13.8. Trans Genic, Inc.

13.9. GenOway S.A.

13.10. Creative Biolabs

13.11. Horizon Discovery Group

13.12. Ingenious Targeting Laboratory

13.13. Biocytogen

13.14. Taconic Biosciences

14. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/dxz9s3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210120005384/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest Stories

  • NBA star's trustee vote shows race fight in South Carolina

    The University of South Carolina’s first African American basketball star, a former NBA veteran running unopposed with the governor's backing, would appear to be a slam dunk for election to a full term on the school’s Board of Trustees. English was one of the first Black players at the University of South Carolina in 1972 and perhaps its most famous. Black lawmakers said the vote is just the latest example of a number of Republicans in the General Assembly dismissing diversity when they elect judges and trustees.

  • Kohl's just launched a massive spring refresh sale and the savings are incredible

    Kohl's is having a huge refresh sale for the home right now, so you can snag major price cuts on cookware, appliances and more—shop our top picks.

  • KBRA Assigns Preliminary Ratings to Mercury Financial Credit Card Master Trust, Series 2021-1

    Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to four classes of notes that will be issued from Mercury Financial Credit Card Master Trust, Series 2021-1 ("MFCCMT 2021-1"), a credit card asset-backed securities transaction. The ratings reflect the initial credit enhancement levels ranging from 33.25% for the Class A notes to 5.00% for the Class D notes. Credit enhancement on the notes consists of i) subordination (except for the class D notes) ii) excess spread generated by the pool of credit card receivables and iii) a reserve account (if funded after the closing date).

  • Mom Gives Birth to Son in Front Seat of Tesla Near George Washington Bridge Exit

    Allison and Blake Goldfarb's son Jordan made his entrance into the world a week early on Jan. 19

  • Global Medical REIT: Q4 Earnings Snapshot

    BETHESDA, Md. (AP) _ Global Medical REIT Inc. (GMRE) on Wednesday reported a key measure of profitability in its fourth quarter. The results exceeded Wall Street expectations. The real estate investment trust, based in Bethesda, Maryland, said it had funds from operations of $12.4 million, or 24 cents per share, in the period.

  • Plant These Lilies for a Beautiful, Fragrant Garden

    Here's why colorful, sweet-smelling lilies should be in your yard. From Country Living

  • Harry Dunn suspect’s bid to dismiss civil claim denied as trial edges closer

    The Dunn family are a step closer to a court showdown, 18 months on from their son’s death.

  • N.L. delays second dose of vaccine to four months, reports three new COVID-19 cases

    ST. JOHN'S, N.L. — Newfoundland and Labrador is extending the interval between the first and second doses of the COVID-19 vaccine to four months. Chief medical officer of health Dr. Janice Fitzgerald said Wednesday the change will see nearly 40,000 more people vaccinated with a single dose by the end of March. "Real-world evidence is now emerging and shows that the first dose of COVID-19 vaccine offers protection for a longer duration," Fitzgerald said. "It will ... help to prevent symptomatic disease, hospitalization and deaths during this most crucial time of higher disease prevalence and limited vaccine supply." As of Wednesday afternoon, the National Advisory Committee on Immunization recommended no more than six weeks between doses of the Pfizer-BioNTech and Moderna vaccines, and no more than 12 weeks between doses of the Oxford-AstraZeneca vaccine. Those recommendations are expected to change. British Columbia raised eyebrows Monday when provincial health officer Dr. Bonnie Henry announced her province would delay the second dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines by up to four months. Henry said Monday the National Advisory Committee on Immunization is expected to issue a statement this week aligning with the decision. Newfoundland and Labrador is still reeling from a COVID-19 outbreak that spread rapidly through the St. John's metro area in mid-February. The outbreak prompted officials to cancel all in-person voting in the provincial election, which was originally scheduled for Feb. 13, and impose provincewide lockdown measures. Fitzgerald announced three new cases of COVID-19 Wednesday and said all were connected to previously identified infections. "We've had several days in a row with only epidemiologically linked cases, and that means that our new cases are linked to previous cases," she said. "This is good news really and indicates that we are heading in the right direction." There are 149 reported active COVID-19 infections in Newfoundland and Labrador, and 147 of those are in the eastern health region, which includes St. John's. Officials said nine people are in hospital due to the disease, including three in intensive care. Fitzgerald said public health is expecting about 7,000 doses of the newly-approved Oxford-AstraZeneca vaccine next week. "We intend to start administering as soon as they arrive," she said, adding that the priority group for the vaccine had not yet been determined, given that officials are recommending it for people under 65. Those in older age groups will continue to be prioritized for the Moderna and Pfizer-BioNTech shots, Fitzgerald said. This report by The Canadian Press was first published March 3, 2021. The Canadian Press

  • Ex-White House doctor bullied colleagues and drank on the job, report finds

    Ex-White House doctor bullied colleagues and drank on the job, report findsNow a Republican congressman, Ronny Jackson also made sexual comments about a female co-worker, Pentagon report saysUS politics – live updates Ronny Jackson in the press briefing room at the White House on 16 January 2018. Photograph: Nicholas Kamm/AFP/Getty Images

  • New York to loosen travel restrictions for Americans who've gotten the COVID-19 vaccine

    "Domestic travelers are no longer required to quarantine or test out within 90 days of full vaccination," Gov. Andrew Cuomo said Wednesday.

  • Austin acquires Sebastian Berhalter from Columbus on loan

    Midfielder Sebastian Berhalter, the 19-year-old son of U.S. national team coach Gregg Berhalter, was acquired by Major League Soccer's new expansion team in Austin, Texas, on Wednesday on a loan from Columbus in exchange for $50,000 in general allocation money. Gregg Berhalter, a former U.S. defender, coached Columbus from 2013-18 before taking over the U.S. team.

  • Philadelphia Fed’s Harker: Don’t expect an interest rate hike ‘anytime in 2022’

    Philadelphia Federal Reserve President Patrick Harker told Yahoo Finance that he does not expect the Fed to raise interest rates in 2022, despite bond market bets that a rate hike could come that year.

  • Buckingham Palace Announces Inquiry Into Bullying Claims Against Meghan Markle

    "We are clearly very concerned about allegations in The Times following claims made by former staff of The Duke and Duchess of Sussex."

  • Dems tighten relief benefits, firm up support for virus bill

    WASHINGTON — President Joe Biden and Democrats agreed to tighten eligibility limits for stimulus checks Wednesday, bowing to party moderates as leaders prepared to move their $1.9 trillion COVID-19 relief bill through the Senate. At the same time, the White House and top Democrats stood by progressives and agreed that the Senate package would retain the $400 weekly emergency unemployment benefits included in the House-passed pandemic legislation. Moderates have wanted to trim those payments to $300 after Republicans have called the bill so heedlessly generous that it would prompt some people to not return to work. The deal-making underscored the balancing act Democrats face as they try squeezing the massive relief measure through the evenly divided, 50-50 Senate. The package, Biden’s signature legislative priority, is his attempt to stomp out the year-old pandemic, revive an economy that’s shed 10 million jobs and bring some semblance of normality to countless upended lives. Democrats have no choice but to broker compromises among themselves, thanks to their mere 10-vote House margin and a Senate they control only with Vice-President Kamala Harris’ tie-breaking vote. The party’s moderate and progressive factions are competing to use their leverage, but without going so far as to scuttle an effort they all support. “He’s pleased with the progress that is being made with the rescue plan,” White House press secretary Jen Psaki said of Biden, reflecting the flexibility he and all Democrats will need to prevail. “He’s always said he’s open to good ideas.” So far, Republicans have presented a unified front against the bill. Senate Minority Leader Mitch McConnell, R-Ky., has said he wants unanimous GOP opposition. But Sen. Lisa Murkowski, R-Alaska, didn't rule out breaking ranks and supporting the measure. She told reporters her state's tourism industry has been walloped by the pandemic and said she's talked to administration officials about “how this helps a state like Alaska.” Democrats were hoping to begin Senate debate later Wednesday, but they faced mountains of GOP amendments and other delays that could take days to plow through. The House will have to approve the Senate’s version before shipping it to Biden, which Democrats want to do before the last round of emergency jobless benefits run dry March 14. “I would expect a very long night into the next day and keep going on,” said Sen. James Lankford, R-Okla., describing GOP plans to force votes. Under the legislation, individuals earning up to $75,000, and couples up to $150,000, would get $1,400 checks per person. The House-approved version would gradually phase down that amount, with individuals making $100,000 and couples earning $200,000 receiving nothing. Under Wednesday’s agreement, the Senate bill would instead halt the payments completely for individuals making $80,000 and couples earning $160,000, said a Democratic official, who described the agreement only on condition of anonymity. That means some people who received the last round of $600 relief checks approved in December wouldn't get anything this time. The liberal Institute on Taxation and Economic Policy estimated that the pared-down Senate eligibility levels means 280 million adults and children would receive stimulus checks, compared to 297 million people under the House plan. West Virginia Sen. Joe Manchin, perhaps the chamber's most conservative Democrat, has favoured lowering the relief check eligibility limits and opposed t he House bill's minimum wage increase. He suggested Wednesday he'd back the emerging Senate legislation, saying it “really does have enough good stuff that we should be able to make this work." In a swipe at moderates, Rep. Mark Pocan, D-Wis., a leader of his chamber’s progressives, called the new phase-out of relief checks a “silly and stupid” effort to appease “the one or two people who can hold things up.” Yet asked if the change could threaten the overall bill, Pocan said, “Let’s hope they don’t screw too many things up. We need to get this done.” Liberals were already angry after Senate Democrats jettisoned the House bill’s minimum wage increase to $15 by 2025. They did so after the Senate parliamentarian said the chamber’s rules wouldn’t allow the boost in the bill and as Manchin and Sen. Kyrsten Sinema, D-Ariz., said they’d oppose its inclusion, sealing its fate. The House version of the relief checks would cost $422 billion, making them the package’s single most expensive item. The two chambers' bills are largely similar, with both bearing money for state and municipal governments, COVID-19 vaccines and testing, schools, health care subsidies and tax breaks for children and lower-earning people. Republicans continued lashing the measure as an overpriced Democratic wish list of liberal causes that lavishes help on many who don’t really need it. “Democrats had a choice,” McConnell said. “They chose to go it alone, tack to the left, leave families' top priorities on the cutting room floor.” “This is not a liberal wish list,” said Senate Majority Leader Chuck Schumer, D-N.Y. “This is an American wish list. When people want checks to help them get out of the morass, that's not a liberal wish list. That's what the American people want.” Slowly, the Senate bill's contours were taking shape. Senate Democrats were removing $1.5 million for a bridge between New York state and Canada and around $140 million for a rapid transit project south of San Francisco after Republicans cast both as pet projects f or Schumer and House Speaker Nancy Pelosi, D—Calif. Aides to both Democratic leaders said the projects weren’t new and had been supported by the Trump administration. Democrats are using special rules that will let them avoid GOP filibusters that would require them to garner an impossible 60 votes to approve the legislation. ___ AP reporter Kevin Freking contributed to this report. Alan Fram, The Associated Press

  • Crystal Palace vs Manchester United LIVE: Result and reaction from Premier League fixture tonight

    Follow all the live action from the top-flight meeting

  • Chelsea FC beat Atletico Madrid 2-0 in Women’s Champions League with Ann-Katrin Berger the penalty hero

    Ann-Katrin Berger was the hero with two penalty saves as Chelsea overcame Sophie Ingle's early dismissal to seal a first-leg 2-0 win over Atletico Madrid in the Women's Champions League. With Sophie Ingle sent off early on, Chelsea had goalkeeper Berger to thank for their commanding position heading into next week's second leg as she saved two Atletico spot-kicks. Ingle was sent off just 12 minutes in, leaving Emma Hayes' side with an uphill battle in the last-16 clash, but they were handed an immediate boost as Deyna Castellanos missed the resulting spot-kick.

  • Invasive remote learning tech scans my retina, records voiceprints and gobbles up my data

    I'm a student, not a bundle of data and biometric information to sell. Virtual learning may be here to stay, but predatory seizure of data must go.

  • StorageVault to Acquire 15 Storage Locations for $100 Million

    TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- STORAGEVAULT CANADA INC. (“StorageVault”) (SVI-TSX-V) has agreed to acquire 15 stores from seven vendor groups (collectively, the “Vendors”) for an aggregate purchase price of $100,000,000, subject to customary adjustments (the “Acquisitions”). Five of the Acquisitions are arm’s length and two, totaling $10,700,000, are related party acquisitions (the “Related Party Acquisitions”) with Access Self Storage Inc. or its affiliates or associates (collectively, “Access”) as the Vendor. It is anticipated that the Acquisitions will close in Q1 and Q2 2021. Seven of the assets are located in Ontario, two in Saskatchewan and six in Alberta. Six of the stores are currently managed by StorageVault. The Acquisitions will result in StorageVault owning 182 stores and owning and managing 221 across Canada. Purchase Price and PaymentThe aggregate purchase price is $100,000,000, subject to adjustments, and is payable by the issuance of an aggregate of up to approximately $15,000,000 of StorageVault common shares to certain of the Vendors based on an agreed upon VWAP ending two days prior to closing, with the remainder of the aggregate purchase price being paid with funds on hand and mortgage financing. Conditions Precedent to the AcquisitionsThe obligations of StorageVault to complete the Acquisitions are subject to conditions including, but not limited to: satisfactory due diligence, obtaining first mortgage commitments, and satisfactory environmental site assessment reports. The obligations of both StorageVault and the Vendors to complete the closing of the Acquisitions are subject to the satisfaction of other customary closing conditions and include acceptance of the TSX Venture Exchange (“TSXV”). None of the seven Vendor group Acquisitions are conditional or contingent on the completion of the other Acquisitions. Exemption from MI 61-101 and TSXV Policy 5.9As Access is a non-arm’s length party to StorageVault, ‎the Related Party Acquisitions are considered “related party transactions” under MI 61-101 and TSXV Policy 5.9. StorageVault is relying on exemptions from the formal valuation and minority approval requirements of MI 61-101 and TSXV Policy 5.9, in respect of the Related Party Acquisitions, pursuant to Section 5.5(b) (Issuer Not Listed on Specified Markets) and Section 5.7(a) (Fair Market Value Not More Than 25% of Market Capitalization) of MI 61-101, respectively. Other InformationThere can be no assurance that the Acquisitions will be completed as proposed or at all. The TSXV has in no way passed upon the merits of the Acquisitions and has neither approved nor disapproved the contents of this news release. No new insiders will be created, nor will any change of control occur, as a result of the ‎Acquisitions. ‎ About StorageVault Canada Inc.StorageVault currently owns and operates 212 storage locations in the provinces of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, and Nova Scotia. StorageVault owns 167 of these locations plus over 4,400 portable storage units representing over 9.2 million rentable square feet on over 525 acres of land. StorageVault also provides professional records management services, such as document and media storage, imaging and shredding services. For further information, contact Mr. Steven Scott or Mr. Iqbal Khan: Tel: 1-877-622-0205 ir@storagevaultcanada.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information in relation to: the proposed Acquisitions‎; the timing for completion of the proposed Acquisitions; the satisfaction of the conditions for completion of the proposed Acquisitions‎; and the issuance of StorageVault common shares to satisfy a portion of the purchase price for certain of the proposed Acquisitions‎‎. This forward-looking information reflects StorageVault’s current beliefs and is based on information currently available to StorageVault and on assumptions StorageVault believes are reasonable. These assumptions include, but are not limited to: the completion of satisfactory due diligence by StorageVault in relation to the proposed Acquisitions‎; execution of purchase agreements for certain of the proposed Acquisitions; the satisfactory fulfilment of all of the conditions precedent to the proposed Acquisitions including satisfactory due diligence‎, obtaining first mortgage commitments, and satisfactory ‎environmental site assessment reports‎; the receipt of all required approvals for the proposed Acquisitions‎, including TSXV acceptance and any third party consents (including for mortgage commitments); the issuance of StorageVault common shares as disclosed above as part of the purchase price for certain of the proposed Acquisitions‎; market acceptance of the proposed Acquisitions‎; the receipt of, and accuracy of the value of, appraisals received for the proposed Acquisitions‎; acceptable financing to complete the proposed Acquisitions‎; the level of activity in the storage business and the economy generally; consumer interest in StorageVault’s services and products; competition and StorageVault’s competitive advantages; and StorageVault’s continued response and ability to navigate the COVID-19 pandemic being ‎consistent with, or better than, its ability and response to date‎. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of StorageVault to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive third party or regulatory approvals; the actual results of StorageVault’s future operations; competition; changes in legislation, including environmental legislation, affecting StorageVault; the timing and availability of external financing on acceptable terms; conclusions of economic evaluations and appraisals; lack of qualified, skilled labour or loss of key individuals; risks related to the COVID-19 pandemic including various recommendations, orders and measures of governmental authorities to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, service disruptions, quarantines, self-isolations, shelters-in-place and social distancing, disruptions to markets, economic activity, financing, supply chains and sales channels, and a deterioration of general economic conditions including a possible national or global recession; and the impact that the COVID-19 pandemic may have on StorageVault which may include: a short-term delay in payments from customers, an increase in accounts receivable and an increase of losses on accounts receivable; decreased demand for the services that StorageVault offers; and a deterioration of financial markets that could limit StorageVault’s ability to obtain external financing. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in StorageVault’s disclosure documents on the SEDAR website at www.sedar.com. Although StorageVault has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of StorageVault as of the date of this news release and, accordingly, is subject to change after such date. However, StorageVault expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

  • Pentagon report: Rep. Ronny Jackson harassed staff, used alcohol on duty as White House physician

    The congressman, who served 25 years in the military, was found to have fostered an abusive and toxic workplace as the White House's top doctor.

  • The Terror review: Easily the most compelling new drama to reach British screens this year

    This ageless story is told with rock-solid characterisation and intelligent, soulful dialogue brought to vivid life by an enviable cast including Jared Harris and Ciaran Hinds